Literature DB >> 35356384

Valvular Heart Disease in Athletes.

Bradley J Petek1, Aaron L Baggish2.   

Abstract

Valvular heart disease is prevalent in older athletes with primarily degenerative valvular disorders and younger athletes with congenital or genetic syndromes. Limited data exist on the risks and benefits of exercise for athletes with underlying valvular disorders, so current guidelines are primarily based upon expert consensus. This review focuses on the current data, guideline recommendations, and emerging clinical conundrums for athletes with common valvular heart conditions including aortic stenosis, bicuspid aortic valve (BAV), mitral regurgitation (MR), mitral valve prolapse (MVP), and thoracic aortic aneurysms.

Entities:  

Keywords:  Athlete; Exercise; Physical activity; Shared decision-making; Valvular disease

Year:  2021        PMID: 35356384      PMCID: PMC8963740          DOI: 10.1007/s11936-021-00950-1

Source DB:  PubMed          Journal:  Curr Treat Options Cardiovasc Med        ISSN: 1092-8464


  61 in total

Review 1.  Eligibility and Disqualification Recommendations for Competitive Athletes With Cardiovascular Abnormalities: Task Force 5: Valvular Heart Disease: A Scientific Statement From the American Heart Association and American College of Cardiology.

Authors:  Robert O Bonow; Rick A Nishimura; Paul D Thompson; James E Udelson
Journal:  Circulation       Date:  2015-11-02       Impact factor: 29.690

2.  The natural course of bicuspid aortic valve in athletes.

Authors:  A Spataro; A Pelliccia; M Rizzo; A Biffi; G Masazza; F Pigozzi
Journal:  Int J Sports Med       Date:  2007-09-13       Impact factor: 3.118

3.  Myocardial adaptations to recreational marathon training among middle-aged men.

Authors:  Jodi L Zilinski; Miranda E Contursi; Stephanie K Isaacs; James R Deluca; Gregory D Lewis; Rory B Weiner; Adolph M Hutter; Pierre A d'Hemecourt; Christopher Troyanos; K Sophia Dyer; Aaron L Baggish
Journal:  Circ Cardiovasc Imaging       Date:  2015-02       Impact factor: 7.792

Review 4.  The endurance athletes heart: acute stress and chronic adaptation.

Authors:  Keith George; Greg P Whyte; Danny J Green; David Oxborough; Rob E Shave; David Gaze; John Somauroo
Journal:  Br J Sports Med       Date:  2012-11       Impact factor: 13.800

Review 5.  Bicuspid aortic valve disease.

Authors:  Samuel C Siu; Candice K Silversides
Journal:  J Am Coll Cardiol       Date:  2010-06-22       Impact factor: 24.094

6.  Prevalence and Clinical Outcome of Athletes With Mitral Valve Prolapse.

Authors:  Stefano Caselli; Federica Mango; John Clark; Natesa G Pandian; Domenico Corrado; Camillo Autore; Antonio Pelliccia
Journal:  Circulation       Date:  2018-05-08       Impact factor: 29.690

7.  Prevalence and clinical significance of left atrial remodeling in competitive athletes.

Authors:  Antonio Pelliccia; Barry J Maron; Fernando M Di Paolo; Alessandro Biffi; Filippo M Quattrini; Cataldo Pisicchio; Alessandra Roselli; Stefano Caselli; Franco Culasso
Journal:  J Am Coll Cardiol       Date:  2005-08-16       Impact factor: 24.094

8.  Reference Values of Aortic Root in Male and Female White Elite Athletes According to Sport.

Authors:  Araceli Boraita; Maria-Eugenia Heras; Francisco Morales; Manuel Marina-Breysse; Alicia Canda; Manuel Rabadan; Maria-Isabel Barriopedro; Amai Varela; Alejandro de la Rosa; José Tuñón
Journal:  Circ Cardiovasc Imaging       Date:  2016-10       Impact factor: 7.792

9.  Global, Regional, and National Burden of Calcific Aortic Valve and Degenerative Mitral Valve Diseases, 1990-2017.

Authors:  Simon Yadgir; Catherine Owens Johnson; Victor Aboyans; Oladimeji M Adebayo; Rufus Adesoji Adedoyin; Mohsen Afarideh; Fares Alahdab; Alaa Alashi; Vahid Alipour; Jalal Arabloo; Samad Azari; Celine M Barthelemy; Catherine P Benziger; Adam E Berman; Ali Bijani; Juan J Carrero; Félix Carvalho; Ahmad Daryani; Andre R Durães; Alireza Esteghamati; Talha A Farid; Farshad Farzadfar; Eduarda Fernandes; Irina Filip; Mohamed M Gad; Samer Hamidi; Simon I Hay; Olayinka Stephen Ilesanmi; Seyed Sina Naghibi Irvani; Mikk Jürisson; Amir Kasaeian; Andre Pascal Kengne; Abdur Rahman Khan; Adnan Kisa; Sezer Kisa; Dhaval Kolte; Navid Manafi; Amir Manafi; George A Mensah; Erkin M Mirrakhimov; Yousef Mohammad; Ali H Mokdad; Ruxandra Irina Negoi; Huong Lan Thi Nguyen; Trang Huyen Nguyen; Molly R Nixon; Catherine M Otto; Shanti Patel; Thomas Pilgrim; Amir Radfar; David Laith Rawaf; Salman Rawaf; Wasiq Faraz Rawasia; Aziz Rezapour; Leonardo Roever; Anas M Saad; Seyedmohammad Saadatagah; Subramanian Senthilkumaran; Karen Sliwa; Berhe Etsay Tesfay; Bach Xuan Tran; Irfan Ullah; Muthiah Vaduganathan; Tommi Juhani Vasankari; Charles D A Wolfe; Naohiro Yonemoto; Gregory A Roth
Journal:  Circulation       Date:  2020-03-29       Impact factor: 29.690

10.  Diffuse myocardial fibrosis in patients with mitral valve prolapse and ventricular arrhythmia.

Authors:  An H Bui; Sébastien Roujol; Murilo Foppa; Kraig V Kissinger; Beth Goddu; Thomas H Hauser; Peter J Zimetbaum; Long H Ngo; Warren J Manning; Reza Nezafat; Francesca N Delling
Journal:  Heart       Date:  2016-08-11       Impact factor: 5.994

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.